GWLL (Goldenwell Biotech) Total Liabilities: $0.38 Mil (As of Mar. 2026)


GWLL Goldenwell Biotech Inc GWLL
30 GF Score
Price $0.90
! 1 Warning Sign
View Full Analysis

What is Goldenwell Biotech Total Liabilities?

Goldenwell Biotech GWLL 30 Total Liabilities is $0.38 Mil as of Mar. 2026. GuruFocus rates GWLL with a GF Score™ of 30/100. The stock has 1 warning sign investors should review.

Goldenwell Biotech's Total Liabilities for the quarter that ended in Mar. 2026 was $0.38 Mil.

Goldenwell Biotech's quarterly Total Liabilities increased from Sep. 2025 ($0.32 Mil) to Dec. 2025 ($0.38 Mil) but then stayed the same from Dec. 2025 ($0.38 Mil) to Mar. 2026 ($0.38 Mil).

Goldenwell Biotech's annual Total Liabilities increased from Dec. 2023 ($0.14 Mil) to Dec. 2024 ($0.27 Mil) and increased from Dec. 2024 ($0.27 Mil) to Dec. 2025 ($0.38 Mil).

Goldenwell Biotech Total Liabilities Historical Data

* Premium members only.

The historical data trend for Goldenwell Biotech's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Goldenwell Biotech Total Liabilities Chart

Goldenwell Biotech Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial 0.16 0.05 0.14 0.27 0.38

Goldenwell Biotech Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.27 0.34 0.32 0.38 0.38
GWLL
30GF Score
Goldenwell Biotech Inc GWLL
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Goldenwell Biotech Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Goldenwell Biotech's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.102+(0.096+0.182
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=0.38

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=0.036--0.344
=0.38

Goldenwell Biotech's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.1+(0.096+0.184
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=0.38

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=0.019--0.361
=0.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $0.38 Mil mean?
Goldenwell Biotech (GWLL) has a Total Liabilities of $0.38 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Goldenwell Biotech and its competitors.
Is Goldenwell Biotech's Total Liabilities too high?
Goldenwell Biotech's current Total Liabilities is $0.38 Mil. Overall, Goldenwell Biotech has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Goldenwell Biotech's Total Liabilities compare to HAIN and LSF?
Goldenwell Biotech's Total Liabilities of $0.38 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Consumer Packaged Goods company?
A good Total Liabilities depends on the Consumer Packaged Goods industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Goldenwell Biotech and its competitors. Goldenwell Biotech's current Total Liabilities is $0.38 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Goldenwell Biotech stock overvalued right now?
Goldenwell Biotech (GWLL) has a current Total Liabilities of $0.38 Mil. The current Total Liabilities is $0.38 Mil. Goldenwell Biotech's overall GF Score™ is 30/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Goldenwell Biotech (GWLL), the current Total Liabilities is $0.38 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Goldenwell Biotech Business Description

Address 581 Boston Mills Road, Suite 300, Hudson, OH, USA, 44236
Goldenwell Biotech Inc is engaged in the research and development, production, and sales of healthcare and supplement products. Its products comprise JI MAI - Bovine Cardiac Vascular Active Peptide, Double Proline AG - 3D Active Collagen Peptide, Cartilage Peptide - Type II collagen peptide, and Sugar Master.
30GF Score

Get the complete analysis for GWLL

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.90
Price